Yes, you can give her rizatriptan
Based on the clinical scenario provided—a woman without coronary artery disease, uncontrolled hypertension, peripheral vascular disease, cerebrovascular disease, hemiplegic migraine, and who is not pregnant or breastfeeding—rizatriptan is appropriate and recommended for acute migraine treatment. 1
Treatment Algorithm
First-Line Approach
Start with an NSAID or acetaminophen at adequate doses for initial migraine treatment 1. If insufficient pain relief occurs despite appropriate dosing:
Add Rizatriptan
Combine a triptan (such as rizatriptan) with an NSAID, or with acetaminophen if NSAIDs are contraindicated 1. The 2025 American College of Physicians guidelines explicitly list rizatriptan among the recommended triptans for acute episodic migraine, with selection based on patient preferences regarding route of administration and cost 1.
Critical Safety Considerations
Absolute Contraindications (Must Screen For)
Rizatriptan is contraindicated in patients with 2:
- Ischemic or vasospastic coronary artery disease
- History of myocardial infarction
- Prinzmetal's angina
- Stroke or transient ischemic attack
- Uncontrolled hypertension
- Peripheral vascular disease
- Hemiplegic or basilar migraine
- Pregnancy or breastfeeding (unknown safety profile) 2
Cardiovascular Risk Assessment Required
For triptan-naive patients with multiple cardiovascular risk factors (increased age, diabetes, hypertension, smoking, obesity, strong family history of CAD), perform cardiovascular evaluation before prescribing rizatriptan 2. Consider administering the first dose in a medically-supervised setting with immediate post-dose ECG 2.
Recent 2025 population-based data (26,054 patients) showed no increased cardiovascular events with triptan use even in patients with existing CV risk factors, though patients using triptans frequently had slightly higher event rates 3. However, the FDA label warnings take precedence over this observational data.
Dosing and Administration
Standard Dosing
- Adults: 5-10 mg per dose
- If headache recurs: May take second dose 2 hours after first dose
- Maximum: 30 mg in 24 hours (e.g., three 10 mg tablets) 2
- Children 6-17 years: Safety of more than 1 dose per 24 hours not established 2
Key Counseling Points
Instruct the patient to 1:
- Begin treatment as soon as possible after migraine onset when pain is mild—this improves efficacy
- Use combination therapy (triptan + NSAID or acetaminophen) for better outcomes
- Avoid medication overuse: ≥10 days per month of triptan use can cause medication overuse headache 1
Important Drug Interactions
Do not combine with 2:
- Other triptans within 24 hours
- Ergot-containing medications within 24 hours
- MAO inhibitors (or within 2 weeks of discontinuation)
Dose adjustment needed with:
- Propranolol: Reduces rizatriptan dose to 5 mg (maximum 15 mg/24 hours) 4
Comparative Efficacy
Rizatriptan 10 mg demonstrates superior efficacy compared to sumatriptan, with faster onset (1 hour vs 2-2.5 hours to peak concentration) and higher bioavailability (45% vs 15%) 5, 6. In head-to-head trials, 40% of patients were pain-free at 2 hours with rizatriptan 10 mg versus 33% with sumatriptan 100 mg 5.
Common Pitfalls to Avoid
- Undertreating: Don't use inadequate NSAID/acetaminophen doses before adding triptan
- Delayed treatment: Treating late in the attack reduces efficacy—emphasize early treatment
- Missing cardiovascular screening: Always assess CV risk factors in triptan-naive patients before first dose
- Medication overuse: Monitor frequency of use; ≥10 days/month triggers rebound headaches
- Chest symptoms misinterpretation: Most chest tightness/pressure with triptans is non-cardiac, but if cardiac origin suspected, evaluate immediately and discontinue if CAD confirmed 2